Live Breaking News & Updates on Puma biotechnology company profile

Stay informed with the latest breaking news from Puma biotechnology company profile on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Puma biotechnology company profile and stay connected to the pulse of your community

StockNews.com Lowers Puma Biotechnology (NASDAQ:PBYI) to Hold

Puma Biotechnology (NASDAQ:PBYI – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday. Separately, HC Wainwright reduced their target price on Puma Biotechnology from $8.00 to $7.00 and set a “buy” rating on the stock in a research report […]

United-states , Puma-biotechnology-company-profile , Goldman-sachs-group-inc , Great-point-partners , Puma-biotechnology-inc , Sei-investments-co , Vanguard-group-inc , Puma-biotechnology , Get-free-report , Biotechnology-trading-down , Sachs-group

Research Analysts Offer Predictions for Puma Biotechnology, Inc.'s Q1 2024 Earnings (NASDAQ:PBYI)

Research Analysts Offer Predictions for Puma Biotechnology, Inc.'s Q1 2024 Earnings (NASDAQ:PBYI)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , Nasdaq , Puma-biotechnology-inc , Zacks-research , Hermes-inc , Puma-biotechnology-company-profile , Geode-capital-management , Jump-financial , Boothbay-fund-management , Puma-biotechnology , Free-report

Puma Biotechnology, Inc. (NASDAQ:PBYI) Short Interest Down 18.6% in March

Puma Biotechnology, Inc. (NASDAQ:PBYI) Short Interest Down 18.6% in March
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Maximof-nougues , Alanh-auerbach , Mackenzie-financial-corp , Puma-biotechnology-inc , Puma-biotechnology-company-profile , Nasdaq , Balyasny-asset-management , Puma-biotechnology , Get-free-report , Street-group

Puma Biotechnology (NASDAQ:PBYI) Receives Buy Rating from HC Wainwright

Puma Biotechnology (NASDAQ:PBYI) Receives Buy Rating from HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Alanh-auerbach , Maximof-nougues , Puma-biotechnology-inc , Puma-biotechnology-company-profile , Mackenzie-financial-corp , Balyasny-asset-management , Puma-biotechnology , Free-report , Street-group , Asset-management

Maximo F. Nougues Sells 15,682 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock

Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Free Report) CFO Maximo F. Nougues sold 15,682 shares of the stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $4.49, for a total transaction of $70,412.18. Following the completion of the sale, the chief financial officer now owns 128,666 shares […]

United-states , Maximof-nougues , Mackenzie-financial-corp , Prudential-financial-inc , Nasdaq , Puma-biotechnology-company-profile , Puma-biotechnology-inc , Balyasny-asset-management , Puma-biotechnology , Get-free-report , Street-group

Puma Biotechnology (NASDAQ:PBYI) Upgraded to "Strong-Buy" by StockNews.com

StockNews.com upgraded shares of Puma Biotechnology (NASDAQ:PBYI – Free Report) from a buy rating to a strong-buy rating in a research note released on Wednesday morning. Separately, HC Wainwright reissued a buy rating and issued a $8.00 price objective on shares of Puma Biotechnology in a research report on Wednesday, September 20th. Read Our Latest […]

United-states , Michael-patrick-miller , Mackenzie-financial-corp , Balyasny-asset-management , Puma-biotechnology-company-profile , Puma-biotechnology-inc , Puma-biotechnology , Free-report , Get-free-report , Director-michael-patrick-miller , Street-group , Asset-management

Puma Biotechnology (NASDAQ:PBYI) Stock Price Crosses Above Two Hundred Day Moving Average of $3.35

Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.35 and traded as high as $4.10. Puma Biotechnology shares last traded at $3.93, with a volume of 258,503 shares traded. Wall Street Analyst Weigh In […]

United-states , Michael-patrick-miller , Nasdaq , Acadian-asset-management , Puma-biotechnology-company-profile , Renaissance-technologies , Blackrock-inc , Puma-biotechnology-inc , Millennium-management , Puma-biotechnology , Get-free-report , Director-michael-patrick-miller

Puma Biotechnology (NASDAQ:PBYI) Given "Buy" Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Puma Biotechnology (NASDAQ:PBYI – Free Report) in a research note released on Wednesday morning, Benzinga reports. HC Wainwright currently has a $8.00 price objective on the biopharmaceutical company’s stock. Other equities research analysts have also issued reports about the stock. StockNews.com started coverage on shares of […]

United-states , Maximof-nougues , Alanh-auerbach , Prudential-financial-inc , Puma-biotechnology-inc , Mackenzie-financial-corp , Panagora-asset-management-inc , Blackrock-inc , Hermes-inc , Puma-biotechnology-company-profile , Securities-exchange-commission

Puma Biotechnology (NASDAQ:PBYI) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Puma Biotechnology (NASDAQ:PBYI – Free Report) in a report issued on Thursday. The brokerage issued a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts also recently issued reports on PBYI. HC Wainwright reiterated a buy rating and set a $8.00 price objective on shares of […]

United-states , Troy-edward-wilson , Maximof-nougues , Commonwealth-equity-services , Securities-exchange-commission , Mackenzie-financial-corp , Balyasny-asset-management , Puma-biotechnology-company-profile , Puma-biotechnology-inc , Puma-biotechnology , Free-report , Exchange-commission

Maximo F. Nougues Sells 14,680 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) Stock

Puma Biotechnology, Inc. (NASDAQ:PBYI – Free Report) CFO Maximo F. Nougues sold 14,680 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $3.31, for a total transaction of $48,590.80. Following the completion of the sale, the chief financial officer now owns […]

United-states , Maximof-nougues , Puma-biotechnology-inc , Prospera-financial-services-inc , Hermes-inc , Prudential-financial-inc , Boothbay-fund-management , Puma-biotechnology-company-profile , Nasdaq , Puma-biotechnology , Free-report